Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I and pharmacokinetic study of trabectedin in soft tissue sarcoma
jRCT2080221134Phase 1
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jun 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of trabectedin in soft tissue sarcoma (STS) (3 arms), sponsored by Taiho Pharmaceutical Co., Ltd. Primary endpoints: Safety and tolerability of trabectedin and Pharmacokinetics of trabectedin.
02
Drugs
trabectedin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on jRCT2080221134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221134.